| Chemical Properties | Back Directory | [Boiling point ]
585.1±50.0 °C(Predicted) | [density ]
1.450±0.06 g/cm3(Predicted) | [solubility ]
DMSO: soluble | [form ]
A solid | [pka]
11.94±0.20(Predicted) | [color ]
White to yellow |
| Hazard Information | Back Directory | [Description]
QLN49417, also known as CDK1 inhibitor 8a, is a selective CDK1 inhibitor. This compound was first reported by Andreani, Aldo; et al in Anti-Cancer Drug Design (2001), 15(6), 447-452. This product has no formal name at the moment. | [Uses]
CDK1-IN-2 is a CDK1 inhibitor (IC50: 5.8 μM)[1]. | [IC 50]
CDK1: 5.8 μM (IC50) | [References]
[1] Jorda R, et al. How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases? J Med Chem. 2018 Oct 25;61(20):9105-9120. DOI:10.1021/acs.jmedchem.8b00049 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
|